DekaBank Deutsche Girozentrale - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$845
-22.3%
27,5150.0%0.00%0.0%
Q2 2023$1,087
-0.6%
27,5150.0%0.00%
-33.3%
Q1 2023$1,094
+2.9%
27,5150.0%0.00%0.0%
Q4 2022$1,063
-99.9%
27,5150.0%0.00%
-25.0%
Q3 2022$1,482,000
-7.1%
27,5150.0%0.00%
-20.0%
Q2 2022$1,596,000
-23.3%
27,5150.0%0.01%0.0%
Q1 2022$2,082,000
+34.6%
27,515
+10.0%
0.01%
+25.0%
Q4 2021$1,547,000
+12.5%
25,015
+2.9%
0.00%0.0%
Q3 2021$1,375,000
-6.5%
24,3150.0%0.00%0.0%
Q2 2021$1,471,000
-14.2%
24,3150.0%0.00%
-33.3%
Q1 2021$1,714,000
+19.9%
24,3150.0%0.01%
+20.0%
Q4 2020$1,430,000
-33.2%
24,315
-33.4%
0.01%
-50.0%
Q3 2020$2,141,000
+109.7%
36,515
+43.1%
0.01%
+66.7%
Q3 2019$1,021,000
-55.9%
25,515
-51.5%
0.01%
-50.0%
Q2 2019$2,313,000
+145.3%
52,630
+156.1%
0.01%
+100.0%
Q1 2019$943,000
+26.7%
20,548
+14.8%
0.01%
+20.0%
Q4 2018$744,000
-21.1%
17,893
-12.9%
0.01%
-16.7%
Q3 2018$943,000
+58.5%
20,548
+7.3%
0.01%
+50.0%
Q2 2018$595,000
+6.1%
19,155
+5.7%
0.00%0.0%
Q1 2018$561,000
-18.5%
18,115
-2.2%
0.00%
-20.0%
Q4 2017$688,0000.0%18,5150.0%0.01%0.0%
Q3 2017$688,000
-22.9%
18,5150.0%0.01%
-28.6%
Q2 2017$892,000
+5.1%
18,5150.0%0.01%
-12.5%
Q1 2017$849,000
+37.4%
18,515
-7.5%
0.01%
+14.3%
Q4 2016$618,000
-1.9%
20,015
+8.1%
0.01%0.0%
Q3 2016$630,000
-10.5%
18,5150.0%0.01%
-12.5%
Q2 2016$704,000
-24.3%
18,515
+1.3%
0.01%
-27.3%
Q1 2016$930,000
-35.2%
18,280
-1.9%
0.01%
-31.2%
Q4 2015$1,435,000
+90.6%
18,630
+1.6%
0.02%
+77.8%
Q3 2015$753,000
-39.6%
18,330
+4.0%
0.01%
-40.0%
Q2 2015$1,247,000
-17.4%
17,630
+3.8%
0.02%
-21.1%
Q1 2015$1,509,000
-13.6%
16,980
-11.8%
0.02%
-13.6%
Q4 2014$1,747,000
-14.2%
19,250
-8.3%
0.02%
-21.4%
Q3 2014$2,035,000
+8.3%
21,000
+2.7%
0.03%0.0%
Q2 2014$1,879,000
+34.2%
20,450
+2.2%
0.03%
+27.3%
Q1 2014$1,400,000
+30.5%
20,000
+5.3%
0.02%
+22.2%
Q4 2013$1,073,000
+20.6%
19,000
+2.7%
0.02%
+12.5%
Q3 2013$890,000
+80.5%
18,500
+6.9%
0.02%
+60.0%
Q2 2013$493,00017,3000.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 1,210,377$37,134,36611.77%
Gagnon Advisors, LLC 180,331$5,532,5554.63%
GAGNON SECURITIES LLC 565,429$17,347,3614.35%
ARDSLEY ADVISORY PARTNERS LP 310,000$9,510,8002.12%
RICE HALL JAMES & ASSOCIATES, LLC 968,485$29,713,1201.89%
AlphaCentric Advisors LLC 103,000$3,160,0401.79%
1492 Capital Management LLC 79,687$2,444,7971.58%
ARDSLEY ADVISORY PARTNERS LP 149,000$4,571,3201.02%
OUTFITTER FINANCIAL LLC 32,305$991,1170.93%
Rock Springs Capital Management LP 1,055,500$32,382,7400.87%
View complete list of PACIRA PHARMACEUTICALS INC shareholders